Biofilms in otitis media and sinusitis

Biofilms in otitis media and sinusitis

Biofilms in otitis media and sinusitis

On this page

Biofilm Basics - The Slime Shield

  • What: Structured communities of bacteria encased in a self-produced, slimy Extracellular Polymeric Substance (EPS) matrix.
  • Matrix Composition: A mix of polysaccharides, proteins, lipids, and extracellular DNA (eDNA).
  • Key Functions:
    • Adherence: Firmly attaches to surfaces (e.g., middle ear mucosa, sinus lining, medical devices).
    • Protection: Shields bacteria from antibiotics (↑ resistance up to 1000x) and host immune responses like phagocytosis.
  • Communication: Bacteria coordinate via quorum sensing.

⭐ Biofilms are a major cause of recurrent and chronic infections because the EPS matrix acts as a physical barrier, dramatically reducing antibiotic penetration and efficacy.

image

Otitis Media - The Ear's Sticky Situation

  • Biofilms are a key factor in chronic and recurrent otitis media (OM), especially otitis media with effusion (OME).
  • Pathogens: Primarily Haemophilus influenzae (non-typeable), Streptococcus pneumoniae, and Moraxella catarrhalis.
  • Mechanism: Bacteria form a slimy extracellular polymeric substance (EPS) matrix on the middle ear mucosa.
    • This matrix acts as a physical barrier, protecting bacteria from antibiotics and host immune responses (e.g., phagocytosis).
    • Leads to persistent inflammation, fluid accumulation (effusion), and conductive hearing loss.

Biofilm formation in nasopharynx and middle ear

Clinical Pearl: Biofilms explain why standard antibiotic courses often fail in chronic OM. Treatment may require higher doses, longer durations, or surgical intervention like tympanostomy tube insertion to mechanically disrupt the biofilm and drain fluid.

Sinusitis - A Nasty Nasal Network

Coronal CT scans of chronic rhinosinusitis

  • Chronic Rhinosinusitis (CRS) & Biofilms

    • Biofilms are a primary driver in CRS, especially with nasal polyps (CRSwNP).
    • They create a persistent nidus of infection, leading to recalcitrant disease.
  • Key Pathogens

    • Frequently polymicrobial.
    • Common isolates: Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenzae.
  • Pathophysiology

    • The biofilm's extracellular matrix shields bacteria from antibiotics and host immune responses.
    • This triggers chronic inflammation, leading to mucosal edema and impaired mucociliary clearance.

⭐ Biofilms are detected in over 80% of mucosal specimens from patients undergoing surgery for CRS.

Clinical Challenges - Breaching the Fortress

  • Diagnostic Hurdles:

    • Standard cultures often yield false negatives; they detect free-floating (planktonic) bacteria, not the sessile forms within the biofilm.
    • Definitive diagnosis may require tissue sampling during surgery (e.g., FESS, myringotomy).
  • Therapeutic Failure:

    • The Extracellular Polymeric Substance (EPS) matrix is a physical barrier, blocking antibiotic penetration.
    • Bacteria in biofilms have ↓ metabolic rates, making them tolerant to many antibiotics.
    • Result: Recurrent/chronic infections despite seemingly appropriate antibiotic therapy.
  • Management Strategy:

    • Physical disruption is the primary goal.
    • Surgical debridement (e.g., FESS) or drainage (tympanostomy tubes) is often necessary.

⭐ Biofilm-related infections are notoriously difficult to eradicate. The presence of Pseudomonas aeruginosa in chronic suppurative otitis media often implies a well-established biofilm, requiring aggressive mechanical and topical treatment.

High‑Yield Points - ⚡ Biggest Takeaways

  • Biofilms are crucial in chronic/recurrent otitis media & sinusitis, acting as a persistent bacterial reservoir.
  • Key pathogens include H. influenzae, S. pneumoniae, and P. aeruginosa.
  • The biofilm matrix provides a shield against antibiotics and host immune responses.
  • This leads to persistent inflammation, often resulting in chronic otitis media with effusion (OME).
  • Biofilms explain why these infections are often refractory to conventional antibiotic therapy.
  • Management may require surgical intervention to physically disrupt the biofilm.

Practice Questions: Biofilms in otitis media and sinusitis

Test your understanding with these related questions

An 8-year-old boy with asthma is brought to the physician because of a 2-week history of facial pain and congestion. His mother states that the nasal discharge was initially clear, but it has become thicker and more purulent over the last week. He has tried multiple over-the-counter oral decongestants and antihistamines, with minimal relief. Current medications include cetirizine, intranasal oxymetazoline, and albuterol. His temperature is 37.7°C (99.8°F), pulse is 100/min, respirations are 14/min, and blood pressure is 110/70 mm Hg. Examination shows congested nasal mucosa with purulent discharge from the nares bilaterally. There is tenderness to palpation over the cheeks, with no transillumination over the maxillary sinuses. Which of the following is the most likely predisposing factor for this patient's current condition?

1 of 5

Flashcards: Biofilms in otitis media and sinusitis

1/8

Rhinosinusitis is most commonly caused by a _____ (bacterial or viral) upper respiratory infection (URI)

TAP TO REVEAL ANSWER

Rhinosinusitis is most commonly caused by a _____ (bacterial or viral) upper respiratory infection (URI)

viral

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial